| Ricorfotide vedotin | CBP-1008 | Phase 3 Clinical | Coherent Biopharma Suzhou Co Ltd | Breast Neoplasms; Carcinoma, Ovarian Epithelial; Carcinoma, Squamous Cell; Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Solid tumours | 詳細 |
| Arfolitixorin | ISO-901; 6R-MTHF | Phase 3 Clinical | Isofol Medical Ab | Colonic Neoplasms; Colorectal Neoplasms; Osteosarcoma; Rectal Neoplasms | 詳細 |
| Rinatabart Sesutecan | GEN1184; GEN-1184; PRO-1184 | Phase 3 Clinical | ProfoundBio (Suzhou) Co Ltd | Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Fallopian Tube Neoplasms; Mesothelioma; Ovarian Neoplasms; Peritoneal Neoplasms; Solid tumours; Triple Negative Breast Neoplasms; Uterine Neoplasms | 詳細 |
| Sofetabart Mipitecan | LY4170156; LY-4170156 | Phase 3 Clinical | Eli Lilly And Company, Loxo Oncology Inc | Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Endometrial Neoplasms; Fallopian Tube Neoplasms; Neoplasm Metastasis; Ovarian Neoplasms; Pancreatic Neoplasms; Peritoneal Neoplasms; Triple Negative Breast Neoplasms; Uterine Cervical Neoplasms | 詳細 |
| Torvutatug Samrotecan | AZD5335; AZD-5335 | Phase 3 Clinical | Astrazeneca Plc | Adenocarcinoma of Lung; Carcinoma, Ovarian Epithelial; Endometrial Neoplasms; Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Diseases; Solid tumours | 詳細 |
| BAT-8006 | BAT8006; BAT-8006 | Phase 3 Clinical | Bio-Thera Solutions Ltd | Carcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Solid tumours | 詳細 |
| Luveltamab tazevibulin | STRO-002 | Phase 2 Clinical | Sutro Biopharma Inc | Carcinoma, Endometrioid; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Endometrial Neoplasms; Fallopian Tube Neoplasms; Leukemia, Myeloid, Acute; Lung Neoplasms; Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Solid tumours | 詳細 |
| EB-NK-FM (FRalpha/MUC16) | EB-NK-FM | Phase 2 Clinical | Beijing Biotech | Carcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Peritoneal Neoplasms | 詳細 |
| EB-NK-MF (MSLN/FRalpha) | EB-NK-MF | Phase 2 Clinical | Beijing Biotech | Carcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Glioblastoma; Glioma; Peritoneal Neoplasms | 詳細 |
| 18F-AzaFol | AzaFol; 18F-AzaFol; [18F]-AzaFol | Phase 2 Clinical | Insel Gruppe AG, University Hospital Bern | Giant Cell Arteritis; Lung Neoplasms; Neoplasms; Ovarian Neoplasms | 詳細 |
| Farletuzumab ecteribulin | MORAb-202 | Phase 2 Clinical | Bristol-Myers Squibb Company, Eisai Co Ltd, Morphotek Inc | Carcinoma, Non-Small-Cell Lung; Ovarian Neoplasms; Solid tumours | 詳細 |
| 4S-CAR-FRa | 4S-CAR-FRa | Phase 2 Clinical | Shenzhen Geno-Immune Medical Institute | Carcinoma, Transitional Cell; Urinary Bladder Neoplasms | 詳細 |
| CBP-1019 | CBP-1019 | Phase 2 Clinical | Coherent Biopharma Suzhou Co Ltd | Breast Neoplasms; Colorectal Neoplasms; Esophageal Neoplasms; Gastrointestinal Neoplasms; Lung Neoplasms; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Solid tumours; Thoracic Neoplasms; Urogenital Neoplasms | 詳細 |
| Noscapine-folate conjugate | | Phase 1 Clinical | Emory University | Hematologic Neoplasms; Inflammation | 詳細 |
| MOv-18 IgE | MOv-18 IgE; MOv18; MOv-18 | Phase 1 Clinical | Cancer Research UK, King'S College London | Neoplasms; Ovarian Neoplasms | 詳細 |
| MOv19-BBz CAR-T cells Therapy | | Phase 1 Clinical | University Of Pennsylvania | Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms | 詳細 |
| ITIL-306 | ITIL-306 | Phase 1 Clinical | Instil Bio Inc | Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Genital Neoplasms, Female; Solid tumours | 詳細 |
| IMGN-151 | IMGN-151 | Phase 1 Clinical | Immunogen Inc | Breast Neoplasms; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Fallopian Tube Neoplasms; Genital Neoplasms, Female; Ovarian Neoplasms; Peritoneal Neoplasms; Uterine Cervical Neoplasms | 詳細 |
| GenSci-140 | GenSci140; GenSci-140 | Phase 1 Clinical | Changchun GeneScience Pharmaceuticals Co Ltd | Ovarian Neoplasms; Solid tumours | 詳細 |
| IBI-3010 | IBI-3010; IBI3010 | Phase 1 Clinical | | Neoplasm Metastasis; Solid tumours | 詳細 |
| SYS-6041 | SYS6041; SYS-6041 | Phase 1 Clinical | Jushi Biopharmaceutical Co Ltd | | 詳細 |
| FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy(Fred Hutchinson Cancer Center) | | Phase 1 Clinical | Fred Hutchinson Cancer Research Center | Leukemia, Myeloid, Acute; Osteosarcoma | 詳細 |
| [177Lu]Lu-EVS459 | GIZ943; GIZ-943; [177Lu]Lu-EVS459; EVS-459 | Phase 1 Clinical | Novartis Pharma Ag | Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Ovarian Neoplasms | 詳細 |
| ZW-191 | ZW-191 | Phase 1 Clinical | Zymeworks Inc | Carcinoma, Non-Small-Cell Lung; Genital Neoplasms, Female; Ovarian Neoplasms; Solid tumours | 詳細 |
| AMT-151 | AMT-151 | Phase 1 Clinical | Multitude Therapeutics Inc | Adenocarcinoma of Lung; Adenocarcinoma, Clear Cell; Carcinoma, Endometrioid; Carcinoma, Ovarian Epithelial; Carcinoma, Pancreatic Ductal; Endometrial Neoplasms; Fallopian Tube Neoplasms; Mesothelioma; Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Solid tumours; Triple Negative Breast Neoplasms | 詳細 |
| UB-TT170 | UB-TT-170; UB_TT170; UB_TT-170; UB-TT170 | Phase 1 Clinical | Umoja BioPharma Inc | | 詳細 |
| CBP-1018 | CBP-1018 | Phase 1 Clinical | Coherent Biopharma Suzhou Co Ltd | Carcinoma, Renal Cell; Lung Neoplasms; Prostatic Neoplasms; Solid tumours | 詳細 |